HOOKIPA Pharma Inc.
HOOKDrugs in Pipeline
2
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 0 past
No catalysts found.
HB-201 intravenous administration.
HPV-Related Squamous Cell Carcinoma
HB-101 vaccine
Cytomegalovirus (CMV) Infection
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
HB-201 intravenous administration. | Phase 2 | HPV-Related Squamous Cell Carcinoma | - | - |
HB-101 vaccine | Phase 2 | Cytomegalovirus (CMV) Infection | - | - |
Frequently asked questions
What is in HOOKIPA Pharma Inc.'s drug pipeline?→
CatalystAlert tracks 2 drug candidates in HOOKIPA Pharma Inc.'s (HOOK) pipeline across Phase 2. Its lead program is HB-201 intravenous administration. (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is HOOKIPA Pharma Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for HOOKIPA Pharma Inc. (HOOK) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track HOOK biotech catalysts?→
Add HOOK to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow HOOKIPA Pharma Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.